Presentation
2 March 2022 Intravital multiphoton autofluorescence imaging is sensitive to changes in T cell and melanoma tumor cell metabolism during immunotherapy
Author Affiliations +
Abstract
Intravital multiphoton microscopy of the metabolic co-enzymes NAD(P)H and FAD (optical metabolic imaging, or OMI) provides label-free imaging of metabolic changes in vivo. Since the metabolism of tumor and immune cells is associated with cancer progression, we aim to study metabolic changes during a triple-combination immunotherapy regimen that cures murine melanoma tumors. Our results demonstrate that intravital OMI can capture tumor and T cell autofluorescence intensity and lifetime changes during immunotherapy. Overall, this technology enables analysis of single cell metabolic changes in vivo to provide insight for immunotherapy development.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Alexa R. Heaton, Anna Hoefges, Peter R. Rehani, Angelica F. Lopez, Nathaniel J. Burkard, Alexander L. Rakhmilevich, Amy K Erbe, Paul M. Sondel, and Melissa C. Skala "Intravital multiphoton autofluorescence imaging is sensitive to changes in T cell and melanoma tumor cell metabolism during immunotherapy", Proc. SPIE PC11972, Label-free Biomedical Imaging and Sensing (LBIS) 2022, PC119720G (2 March 2022); https://doi.org/10.1117/12.2607108
Advertisement
Advertisement
KEYWORDS
Tumors

Melanoma

Mode conditioning cables

Auto-fluorescence imaging

In vivo imaging

Single photon

Skin

Back to Top